Key result
Abnormal left ventricular global longitudinal strain was associated with a higher risk of in-hospital mortality in patients with COVID-19.
Why the study?
COVID-19 can cause cardiac injury resulting in abnormal RV or LV function with worse outcomes, leading to the hypothesis that 2D speckle-tracking LV GLS and RV FWS can serve as markers of subclinical cardiac injury predicting mortality.
Does abnormal left ventricular global longitudinal strain predict in-hospital mortality in patients hospitalized with COVID-19?
Cohort (n=48)
Does abnormal left ventricular global longitudinal strain predict in-hospital mortality in patients hospitalized with COVID-19?
In patients hospitalized with COVID-19, abnormal left ventricular global longitudinal strain (> -13.8%) is a significant predictor of in-hospital mortality, even in those with normal ejection fraction.
Answers are grounded in this paper and cite their sources.
May inform risk stratification in COVID-19; leaves open need for validation before clinical adoption.
Coronavirus disease 2019 (COVID-19) can cause cardiac injury resulting in abnormal right or left ventricular function (RV/LV) with worse outcomes. We hypothesized that two-dimensional (2D) speckle-tracking assessment of LV global longitudinal strain (GLS) and RV free wall strain (FWS) by transthoracic echocardiography can assist as markers for subclinical cardiac injury predicting increased mortality. We performed 2D strain analysis via proprietary software in 48 patients hospitalized with COVID-19. Clinical information, demographics, comorbidities, and lab values were collected via retrospective chart review. The primary outcome was in-hospital mortality based on an optimized abnormal LV GLS value via ROC analysis and RV FWS. The optimal LV GLS cutoff to predict death was −13.8%, with a sensitivity of 85% (95% CI 55–98%) and specificity of 54% (95% CI 36–71%). Abnormal LV GLS >-13.8% was associated with a higher risk of death [unadjusted hazard ratio 5.15 (95% CI 1.13–23.45), p = 0.034], which persisted after adjustment for clinical variables. Among patients with LV ejection fraction (LVEF) >50%, those with LV GLS > −13.8% had higher mortality compared to those with LV GLS <-13.8% (41% vs. 10%, p = 0.030). RV FWS value was higher in patients with LV GLS >-13.8% (−13.7 ± 5.9 vs. −19.6 ± 6.7, p = 0.003), but not associated with decreased survival. Abnormal LV strain with a cutoff of >−13.8% in patients with COVID-19 is associated with significantly higher risk of death. Despite normal LVEF, abnormal LV GLS predicted worse outcomes in patients hospitalized with COVID-19. There was no mortality difference based on RV strain.
No takes yet. Share an insight, caveat, or question.
Park et al. (2021) conducted a cohort in COVID-19 (n=48). Abnormal left ventricular global longitudinal strain (>-13.8%) vs. Normal left ventricular global longitudinal strain (<-13.8%) was evaluated on In-hospital mortality (HR 5.15, 95% CI 1.13-23.45, p=0.034). Abnormal left ventricular global longitudinal strain was associated with a higher risk of in-hospital mortality in patients with COVID-19.
Synapse has enriched 10 related papers. Consider them for comparative context: